Yıl: 2022 Cilt: 28 Sayı: 2 Sayfa Aralığı: 125 - 133 Metin Dili: İngilizce DOI: 10.14744/tjtes.2020.89499 İndeks Tarihi: 01-11-2022

Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?

Öz:
BACKGROUND: We aimed to investigate antioxidant and neuroprotective properties of chlorogenic acid in spinal cord injury (SCI). METHODS: Twenty-one rats were divided into three groups. Laminectomy was performed in group L (n=7), spinal cord trauma was induced in group T (n=7), and spinal cord trauma was induced and chlorogenic acid treatment was started in group C (n=7). Blood samples were collected to analyze baseline values and the 12th h, 1st day, 3rd day, and 5th day catalase, native thiol (NT), total thiol (TT), disulfide (SS), SS/TT, SS/NT, and NT/TT levels. Functional analysis with Basso-Beattie and Bresnahan scores was performed at the same time points. Total antioxidant status (TAS), total oxidative stress, oxidative stress index, and cyclooxygenase-2 (Cox-2) were examined in the spinal cord of rats euthanized on day 7; results were statistically analyzed. RESULTS: On day 7, catalase levels in Group C were significantly higher than baseline levels, whereas those in Group T were signifi cantly lower than baseline levels; Group L showed no significant difference (p=0.008). SS values on day 7 were lower in Group T than in Groups C and L. Group C showed the lowest decrease in NT/TT level after trauma. On day 7, SS/TT level was high in Group T but stable in Groups C and L (p=0.04). Histopathological examination revealed significantly lower Cox-2 and TAS levels in Group C than in Group T (p=0.003, p=0.017, respectively). CONCLUSION: In this study, SCI was primarily examined through thiol-SS balance, and it was demonstrated by experimental mod els that chlorogenic acid has antioxidant and neuroprotective effects in SCI.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
  • 1. Liu J, Peng L, Li J. The lipoxin A4 receptor agonist BML-111 alleviates inflammatory injury and oxidative stress in spinal cord injury. Med Sci Monit 2020;26:e919883.
  • 2. Liu Z, Yao X, Jiang W, Li W, Zhu S, Liao C, et al. Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-kappaB signaling pathway and pyroptosis after secondary spinal cord injury. J Neuroinflammation 2020;17:90.
  • 3. Lou L, Zhou J, Liu Y, Wei YI, Zhao J, Deng J, et al. Chlorogenic acid induces apoptosis to inhibit inflammatory proliferation of IL-6-in duced fibroblast-like synoviocytes through modulating the activation of JAK/STAT and NF-kappaB signaling pathways. Exp Ther Med 2016;11:2054–60.
  • 4. Erel O, Erdogan S. Thiol disulfide homeostasis: An integrated approach with biochemical and clinical aspects. Turk J Med Sci 2020;50:1728–38.
  • 5. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014;47:326–32.
  • 6. Giden R, Gokdemir MT, Erel O, Buyukaslan H, Karabag H. The rela tionship between serum thiol levels and thiol/disulfide homeostasis with head trauma in children. Clin Lab 2018;64:163–8.
  • 7. Gunduztepe Y, Bukan N, Zorlu E, Karaman Y, Topkan TA, Gurbuz N, et al. The evaluation of thiol-disulfite balance, ischemia albumin mod ification and seruloplazmine as a new oxidative stress in mild cognitive impairment and early stage alzheimer’s disease patients. J Clin Neurosci 2020;75:188–94.
  • 8. Ivanov AV, Alexandrin VV, Paltsyn AA, Nikiforova KA, Virus ED, Luzy anin BP, et al. Plasma low-molecular-weight thiol/disulphide homeosta sis as an early indicator of global and focal cerebral ischaemia. Redox Rep 2017;22:460–6.
  • 9. Liu D, Wang H, Zhang Y, Zhang Z. Protective effects of chlorogenic acid on cerebral ischemia/reperfusion injury rats by regulating oxidative stress-related Nrf2 pathway. Drug Des Dev Ther 2020;14:51–60.
  • 10. Lou Z, Wang H, Zhu S, Ma C, Wang Z. Antibacterial activity and mech anism of action of chlorogenic acid. J Food Sci 2011;76:M398–403.
  • 11. Naveed M, Hejazi V, Abbas M, Kamboh AA, Khan GJ, Shumzaid M, et al. Chlorogenic acid (CGA): A pharmacological review and call for fur ther research. Biomed Pharmacother 2018;97:67–74.
  • 12. Stefanello N, Schmatz R, Pereira LB, Rubin MA, da Rocha JB, Fac co G, et al. Effects of chlorogenic acid, caffeine, and coffee on behav ioral and biochemical parameters of diabetic rats. Mol Cell Biochem 2014;388:277–86.
  • 13. Tajik N, Tajik M, Mack I, Enck P. The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: A comprehen sive review of the literature. Eur J Nutr 2017;56:2215–44.
  • 14. Huang S, Wang LL, Xue NN, Li C, Guo HH, Ren TK, et al. Chlorogen ic acid effectively treats cancers through induction of cancer cell differen tiation. Theranostics 2019;9:6745–63.
  • 15. Hermawati E, Arfian N, Mustofa M, Partadiredja G. Chlorogenic acid ameliorates memory loss and hippocampal cell death after transient glob al ischemia. Eur J Neurosci 2020;51:651–69.
  • 16. Wang S, Wei H, Cai M, Lu Y, Hou W, Yang Q, et al. Genistein attenuates brain damage induced by transient cerebral ischemia through up-regula tion of ERK activity in ovariectomized mice. Int J Biol Sci 2014;10:457– 65.
  • 17. Shen W, Qi R, Zhang J, Wang Z, Wang H, Hu C, et al. Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurons. Brain Res Bull 2012;88:487–94.
  • 18. Erel O. A novel automated direct measurement method for total antiox idant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277–85.
  • 19. Erel O. A new automated colorimetric method for measuring total oxi dant status. Clin Biochem 2005;38:1103–11.
  • 20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75.
  • 21. Tosovic J, Markovic S, Markovic JM, Mojovic M, Milenkovic D. Antioxi dative mechanisms in chlorogenic acid. Food Chem 2017;237:390–8.
  • 22. Miao M, Cao L, Li R, Fang X, Miao Y. Protective effect of chlorogenic acid on the focal cerebral ischemia reperfusion rat models. Saudi Pharm J 2017;25:556–63.
  • 23. Islam MT. Oxidative stress and mitochondrial dysfunction-linked neuro degenerative disorders. Neurol Res 2017;39:73–82.
  • 24. Nandi A, Yan LJ, Jana CK, Das N. Role of catalase in oxidative stress and age-associated degenerative diseases. Oxid Med Cell Longev 2019;2019:9613090.
  • 25. Vaziri ND, Lee YS, Lin CY, Lin VW, Sindhu RK. NAD(P)H oxi dase, superoxide dismutase, catalase, glutathione peroxidase and ni tric oxide synthase expression in subacute spinal cord injury. Brain Res 2004;995:76–83.
  • 26. Kodydkova J, Vavrova L, Kocik M, Zak A. Human catalase, its polymor phisms, regulation and changes of its activity in different diseases. Folia Biol (Praha) 2014;60:153–67.
  • 27. Kong G, Huang Z, Ji W, Wang X, Liu J, Wu X, et al. The ketone me tabolite beta-hydroxybutyrate attenuates oxidative stress in spinal cord injury by suppression of Class I histone deacetylases. J Neurotrauma 2017;34:2645–55.
  • 28. Samarghandian S, Azimi-Nezhad M, Farkhondeh T, Samini F. Anti-ox idative effects of curcumin on immobilization-induced oxidative stress in rat brain, liver and kidney. Biomed Pharmacother 2017;87:223–9.
  • 29. Bao F, Liu D. Peroxynitrite generated in the rat spinal cord induces apop totic cell death and activates caspase-3. Neuroscience 2003;116:59–70.
  • 30. Hall ED. Antioxidant therapies for acute spinal cord injury. Neurothera peutics 2011;8:152–67.
  • 31. Lu J, Ashwell KW, Waite P. Advances in secondary spinal cord injury: Role of apoptosis. Spine (Phila Pa 1976) 2000;25:1859–66.
  • 32. Klusman I, Schwab ME. Effects of pro-inflammatory cytokines in exper imental spinal cord injury. Brain Res 1997;762:173–84.
  • 33. Singh E, Devasahayam G. Neurodegeneration by oxidative stress: A re view on prospective use of small molecules for neuroprotection. Mol Biol Rep 2020;47:3133–40.
  • 34. Dumont RJ, Verma S, Okonkwo DO, Hurlbert RJ, Boulos PT, Ellegala DB, et al. Acute spinal cord injury, part II: Contemporary pharmacother apy. Clin Neuropharmacol 2001;24:265–79.
APA Bal E, Hanalioglu S, Apaydin A, bal c, ŞENAT A, Gumuskaya B, BAHADIR B, Turkoglu O (2022). Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?. , 125 - 133. 10.14744/tjtes.2020.89499
Chicago Bal Ercan,Hanalioglu Sahin,Apaydin Aydın Sinan,bal ceylan,ŞENAT Almila,Gumuskaya Berrak,BAHADIR BURAK,Turkoglu Omer Faruk Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?. (2022): 125 - 133. 10.14744/tjtes.2020.89499
MLA Bal Ercan,Hanalioglu Sahin,Apaydin Aydın Sinan,bal ceylan,ŞENAT Almila,Gumuskaya Berrak,BAHADIR BURAK,Turkoglu Omer Faruk Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?. , 2022, ss.125 - 133. 10.14744/tjtes.2020.89499
AMA Bal E,Hanalioglu S,Apaydin A,bal c,ŞENAT A,Gumuskaya B,BAHADIR B,Turkoglu O Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?. . 2022; 125 - 133. 10.14744/tjtes.2020.89499
Vancouver Bal E,Hanalioglu S,Apaydin A,bal c,ŞENAT A,Gumuskaya B,BAHADIR B,Turkoglu O Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?. . 2022; 125 - 133. 10.14744/tjtes.2020.89499
IEEE Bal E,Hanalioglu S,Apaydin A,bal c,ŞENAT A,Gumuskaya B,BAHADIR B,Turkoglu O "Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?." , ss.125 - 133, 2022. 10.14744/tjtes.2020.89499
ISNAD Bal, Ercan vd. "Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?". (2022), 125-133. https://doi.org/10.14744/tjtes.2020.89499
APA Bal E, Hanalioglu S, Apaydin A, bal c, ŞENAT A, Gumuskaya B, BAHADIR B, Turkoglu O (2022). Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?. Ulusal Travma ve Acil Cerrahi Dergisi, 28(2), 125 - 133. 10.14744/tjtes.2020.89499
Chicago Bal Ercan,Hanalioglu Sahin,Apaydin Aydın Sinan,bal ceylan,ŞENAT Almila,Gumuskaya Berrak,BAHADIR BURAK,Turkoglu Omer Faruk Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?. Ulusal Travma ve Acil Cerrahi Dergisi 28, no.2 (2022): 125 - 133. 10.14744/tjtes.2020.89499
MLA Bal Ercan,Hanalioglu Sahin,Apaydin Aydın Sinan,bal ceylan,ŞENAT Almila,Gumuskaya Berrak,BAHADIR BURAK,Turkoglu Omer Faruk Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?. Ulusal Travma ve Acil Cerrahi Dergisi, vol.28, no.2, 2022, ss.125 - 133. 10.14744/tjtes.2020.89499
AMA Bal E,Hanalioglu S,Apaydin A,bal c,ŞENAT A,Gumuskaya B,BAHADIR B,Turkoglu O Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?. Ulusal Travma ve Acil Cerrahi Dergisi. 2022; 28(2): 125 - 133. 10.14744/tjtes.2020.89499
Vancouver Bal E,Hanalioglu S,Apaydin A,bal c,ŞENAT A,Gumuskaya B,BAHADIR B,Turkoglu O Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?. Ulusal Travma ve Acil Cerrahi Dergisi. 2022; 28(2): 125 - 133. 10.14744/tjtes.2020.89499
IEEE Bal E,Hanalioglu S,Apaydin A,bal c,ŞENAT A,Gumuskaya B,BAHADIR B,Turkoglu O "Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?." Ulusal Travma ve Acil Cerrahi Dergisi, 28, ss.125 - 133, 2022. 10.14744/tjtes.2020.89499
ISNAD Bal, Ercan vd. "Can chlorogenic acid reduce oxidative stress and in an experimental spinal cord injury?". Ulusal Travma ve Acil Cerrahi Dergisi 28/2 (2022), 125-133. https://doi.org/10.14744/tjtes.2020.89499